Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 11.11.2019 | EN | Official Journal of the European Union | C 383/79 |

---

Action brought on 30 September 2019 – Allergan Holdings France v EUIPO – Dermavita (JUVEDERM ULTRA)

(Case T-664/19)

(2019/C 383/88)

Language of the case: English

Parties

Applicant: Allergan Holdings France (Courbevoie, France) (represented by: J. Day, Solicitor)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Dermavita Co. Ltd (Beirut, Lebanon)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant before the General Court

Trade mark at issue: European Union word mark JUVEDERM ULTRA – European Union trade mark No 6 295 638

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 18 July 2019 in Joined Cases R 1655/2018-4 and R 1723/2018-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision insofar as it revokes the EUTM No. 6295638 JUVEDERM ULTRA for the contested goods; |

|  |  |
| --- | --- |
| — | order EUIPO and Dermavita Co. Ltd. to bear their own costs and pay those of the applicant. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Articles 58(1) and 64(5) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)